Diabetic patients with COVID-19 may have an increased risk of retinal involvement and worsening of existing diabetic retinopathy due to direct activation of the transmembrane glycoprotein CD147 expressed mainly in retinal ganglion cells or indirectly through the cytokine storm associated with COVID-19 [15]. Here, BSG is linked to COVID-19.